Adenosine Receptor Blockade With Ciforadenant Plus /- Atezolizumab In Advanced Metastatic Castration-Resistant Prostate Cancer (Mcrpc)
JOURNAL OF CLINICAL ONCOLOGY(2020)
摘要
129Background: Adenosine, generated by the ectonucleotidase CD73, mediates immunosuppression within the tumor microenvironment by triggering adenosine 2A receptors (A2AR) on immune cells. Tumor CD7...
更多查看译文
关键词
prostate cancer,mcrpc,castration-resistant
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要